Literature DB >> 19876583

Immune changes in post-menopausal osteoporosis: the Immunos study.

V Breuil1, M Ticchioni, J Testa, C H Roux, P Ferrari, J P Breittmayer, C Albert-Sabonnadière, J Durant, F De Perreti, A Bernard, L Euller-Ziegler, G F Carle.   

Abstract

UNLABELLED: The phenotypic and functional characteristics of immune cells of osteoporotic women compared to healthy controls similar for age and estrogen level showed for the first time significant changes in several B lymphocytes populations in postmenopausal osteoporosis, related to bone mineral density (BMD) and fractures, and a significant lower basal secretion of interferon-gamma (IFN-gamma) by CD4(+).
INTRODUCTION: To investigate the interactions between bone and immune system, we studied the phenotypic and functional characteristics of immune cells of 26 postmenopausal women with osteoporotic (OP) fractures compared to 24 healthy controls.
METHODS: We analyzed surface markers of peripheral B, CD4(+) and CD8(+) lymphocytes and cytokine secretion in supernatants of these cells cultured with or without stimulation. Body composition was assessed by dual energy X-ray absorptiometry.
RESULTS: The two groups were similar for age and estrogen level. OP women had a significantly lower body mass index, fat mass, and lean mass. The number of CD19(+), CD19(+)/CD27(+), CD19(+)/CD27(+)/CD5(-)/CD38(+) and CD19(+)/CD27(+)/RANK(+), CD4(+)/CD27(+)/CD45RA(-)/RANK(+), and CD4(+)/CD27(+)/CD45RA(-)/CD28(+) was lower in OP women and positively correlated to BMD. In OP women, under basal conditions, CD4(+) secreted less IFN-gamma and B lymphocytes more granulocyte macrophage colony-stimulating factor (GM-CSF). GM-CSF was positively correlated to fracture rate and negatively to BMD.
CONCLUSIONS: Our results suggest that, regardless of age and estrogen status, postmenopausal OP is associated with immune changes, highlighting a possible role of IFN-gamma in the pathophysiology of OP and reporting, for the first time, changes in several B lymphocyte populations. These alterations may reflect the frailty observed after fracture, providing new insight into the mechanisms of morbidity and mortality associated with OP fractures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876583     DOI: 10.1007/s00198-009-1018-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  42 in total

Review 1.  Aging, immunity and cancer.

Authors:  Frances T Hakim; Francis A Flomerfelt; Michael Boyiadzis; Ronald E Gress
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

2.  Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis.

Authors:  S X Zheng; Y Vrindts; M Lopez; D De Groote; P F Zangerle; J Collette; N Franchimont; V Geenen; A Albert; J Y Reginster
Journal:  Maturitas       Date:  1997-01       Impact factor: 4.342

3.  Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis.

Authors:  Y Imai; T Tsunenari; M Fukase; T Fujita
Journal:  J Bone Miner Res       Date:  1990-04       Impact factor: 6.741

4.  Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.

Authors:  Marianne C Walsh; Gary R Hunter; Margaret Barbara Livingstone
Journal:  Osteoporos Int       Date:  2005-07-02       Impact factor: 4.507

5.  Age-related changes in body composition of healthy and osteoporotic women.

Authors:  G Martini; R Valenti; S Giovani; R Nuti
Journal:  Maturitas       Date:  1997-05       Impact factor: 4.342

6.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

7.  Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Authors:  P Ravn; G Cizza; N H Bjarnason; D Thompson; M Daley; R D Wasnich; M McClung; D Hosking; A J Yates; C Christiansen
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

8.  Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.

Authors:  Claudine Blin-Wakkach; Abdelilah Wakkach; Nathalie Rochet; Georges F Carle
Journal:  J Bone Miner Res       Date:  2004-03-22       Impact factor: 6.741

Review 9.  Osteoporosis and inflammation.

Authors:  Gregory R Mundy
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

10.  Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis.

Authors:  S Visvanathan; D van der Heijde; A Deodhar; C Wagner; D G Baker; J Han; J Braun
Journal:  Ann Rheum Dis       Date:  2008-05-21       Impact factor: 19.103

View more
  22 in total

Review 1.  Osteoimmunology: from mice to humans.

Authors:  Patrizia D'Amelio; Francesca Sassi
Journal:  Bonekey Rep       Date:  2016-05-18

2.  Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: The Cardiovascular Health Study.

Authors:  Rodrigo J Valderrábano; Petra Buzkova; Po-Yin Chang; Neil A Zakai; Howard A Fink; John A Robbins; Jennifer S Lee; Joy Y Wu
Journal:  Bone       Date:  2018-11-15       Impact factor: 4.398

3.  Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: Results from CRIC study.

Authors:  Moshrik Abd Alamir; Vlad Radulescu; Michael Goyfman; Emile R Mohler; Yan Lin Gao; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2015-07-09       Impact factor: 5.162

Review 4.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

5.  Serum interferon gamma concentration is associated with bone mineral density in overweight boys.

Authors:  L Utsal; V Tillmann; M Zilmer; J Mäestu; P Purge; M Saar; E Lätt; T Jürimäe; K Maasalu; J Jürimäe
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

6.  Diet, weight, cytokines and bone health in postmenopausal women.

Authors:  C A Gunn; J L Weber; M C Kruger
Journal:  J Nutr Health Aging       Date:  2014-05       Impact factor: 4.075

7.  Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.

Authors:  Heather A Cole; Tetsuro Ohba; Jeffry S Nyman; Haro Hirotaka; Justin M M Cates; Matthew J Flick; Jay L Degen; Jonathan G Schoenecker
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

8.  Integrative computational approach to evaluate risk genes for postmenopausal osteoporosis.

Authors:  Yingjun Sheng; Jilei Tang; Kewei Ren; Lydia C Manor; Hongbao Cao
Journal:  IET Syst Biol       Date:  2018-06       Impact factor: 1.615

Review 9.  Immunology of Osteoporosis: A Mini-Review.

Authors:  Peter Pietschmann; Diana Mechtcheriakova; Anastasia Meshcheryakova; Ursula Föger-Samwald; Isabella Ellinger
Journal:  Gerontology       Date:  2015-06-17       Impact factor: 5.140

Review 10.  Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective.

Authors:  Renqing Zhao
Journal:  Int J Med Sci       Date:  2012-10-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.